227 related articles for article (PubMed ID: 30578542)
1. Comparing Vitamin D Supplementation Versus Placebo for Urgency Urinary Incontinence: A Pilot Study.
Markland AD; Tangpricha V; Mark Beasley T; Vaughan CP; Richter HE; Burgio KL; Goode PS
J Am Geriatr Soc; 2019 Mar; 67(3):570-575. PubMed ID: 30578542
[TBL] [Abstract][Full Text] [Related]
2. Superiority of fesoterodine 8 mg vs 4 mg in reducing urgency urinary incontinence episodes in patients with overactive bladder: results of the randomised, double-blind, placebo-controlled EIGHT trial.
Chapple C; Schneider T; Haab F; Sun F; Whelan L; Scholfield D; Dragon E; Mangan E
BJU Int; 2014 Sep; 114(3):418-26. PubMed ID: 24552358
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of fesoterodine versus tolterodine in older and younger subjects with overactive bladder: a post hoc, pooled analysis from two placebo-controlled trials.
DuBeau CE; Morrow JD; Kraus SR; Creanga D; Bavendam T
Neurourol Urodyn; 2012 Nov; 31(8):1258-65. PubMed ID: 22907761
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of vibegron, a novel β3-adrenoreceptor agonist, on severe urgency urinary incontinence related to overactive bladder: post hoc analysis of a randomized, placebo-controlled, double-blind, comparative phase 3 study.
Yoshida M; Takeda M; Gotoh M; Yokoyama O; Kakizaki H; Takahashi S; Masumori N; Nagai S; Minemura K
BJU Int; 2020 May; 125(5):709-717. PubMed ID: 31991511
[TBL] [Abstract][Full Text] [Related]
5. Comparison of fesoterodine and tolterodine extended release for the treatment of overactive bladder: a head-to-head placebo-controlled trial.
Herschorn S; Swift S; Guan Z; Carlsson M; Morrow JD; Brodsky M; Gong J
BJU Int; 2010 Jan; 105(1):58-66. PubMed ID: 20132103
[TBL] [Abstract][Full Text] [Related]
6. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.
Chapple C; Sievert KD; MacDiarmid S; Khullar V; Radziszewski P; Nardo C; Thompson C; Zhou J; Haag-Molkenteller C
Eur Urol; 2013 Aug; 64(2):249-56. PubMed ID: 23608668
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of fesoterodine compared with extended-release tolterodine in men and women with overactive bladder.
Ginsberg D; Schneider T; Kelleher C; Van Kerrebroeck P; Swift S; Creanga D; Martire DL
BJU Int; 2013 Aug; 112(3):373-85. PubMed ID: 23826844
[TBL] [Abstract][Full Text] [Related]
8. Fesoterodine in patients with overactive bladder syndrome: can the severity of baseline urgency urinary incontinence predict dosing requirement?
Cardozo L; Khullar V; Wang JT; Guan Z; Sand PK
BJU Int; 2010 Sep; 106(6):816-21. PubMed ID: 20151972
[TBL] [Abstract][Full Text] [Related]
9. Association of Pharmacologic Treatment of Urgency Urinary Incontinence With Sleep Quality and Daytime Sleepiness.
Warsi QA; Huang AJ; Hess R; Arya LA; Richter HE; Bradley CS; Rogers RG; Myers DL; Johnson KC; Winkelman WD; Gregory WT; Kraus SR; Schembri M; Brown JS; Stone KL; Subak LL
Obstet Gynecol; 2018 Feb; 131(2):204-211. PubMed ID: 29324595
[TBL] [Abstract][Full Text] [Related]
10. The effect of vitamin D on urgent urinary incontinence in postmenopausal women.
Arjmand M; Abbasi H; Behforouz A
Int Urogynecol J; 2023 Aug; 34(8):1955-1960. PubMed ID: 36826518
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of the symptoms of overactive bladder in women with mixed urinary incontinence and idiopathic urge urinary incontinence.].
Arribillaga L; Bengió RG; Ledesma M; Montedoro A; Orellana S; Pisano F; Bengió RH
Arch Esp Urol; 2018 Jul; 71(6):531-536. PubMed ID: 29991661
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of combinations of mirabegron and solifenacin compared with monotherapy and placebo in patients with overactive bladder (SYNERGY study).
Herschorn S; Chapple CR; Abrams P; Arlandis S; Mitcheson D; Lee KS; Ridder A; Stoelzel M; Paireddy A; van Maanen R; Robinson D
BJU Int; 2017 Oct; 120(4):562-575. PubMed ID: 28418102
[TBL] [Abstract][Full Text] [Related]
13. Factors predicting the treatment success of bladder training for urgency urinary incontinence.
Yıldız N; Özlü A
Neurourol Urodyn; 2022 Nov; 41(8):1809-1816. PubMed ID: 35989536
[TBL] [Abstract][Full Text] [Related]
14. Correlations among improvements in urgency urinary incontinence, health-related quality of life, and perception of bladder-related problems in incontinent subjects with overactive bladder treated with tolterodine or placebo.
Van Kerrebroeck PE; Kelleher CJ; Coyne KS; Kopp Z; Brodsky M; Wang JT
Health Qual Life Outcomes; 2009 Feb; 7():13. PubMed ID: 19226471
[TBL] [Abstract][Full Text] [Related]
15. Persistence of urgency and urge urinary incontinence in women with mixed urinary symptoms after midurethral slings: a multivariate analysis.
Lee JK; Dwyer PL; Rosamilia A; Lim YN; Polyakov A; Stav K
BJOG; 2011 Jun; 118(7):798-805. PubMed ID: 21392244
[TBL] [Abstract][Full Text] [Related]
16. Effect of vitamin D supplementation on urinary incontinence in older women: ancillary findings from a randomized trial.
Markland AD; Vaughan C; Huang A; Kim E; Bubes VY; Tangpricha V; Buring J; Lee IM; Cook N; Manson JE; Grodstein F
Am J Obstet Gynecol; 2022 Apr; 226(4):535.e1-535.e12. PubMed ID: 34678177
[TBL] [Abstract][Full Text] [Related]
17. Response to fesoterodine in patients with an overactive bladder and urgency urinary incontinence is independent of the urodynamic finding of detrusor overactivity.
Nitti VW; Rovner ES; Bavendam T
BJU Int; 2010 May; 105(9):1268-75. PubMed ID: 19889062
[TBL] [Abstract][Full Text] [Related]
18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
19. Ambulatory urodynamic monitoring of women with overactive bladder syndrome during single voiding cycle.
Dokmeci F; Cetinkaya SE; Seval MM; Dai O
Eur J Obstet Gynecol Reprod Biol; 2017 May; 212():126-131. PubMed ID: 28355584
[TBL] [Abstract][Full Text] [Related]
20. Radiofrequency as the New Opportunity in Treating Overactive Bladder and Urge Urinary Incontinence-A Single-Arm Pilot Study.
Franić D; Franić Ivanišević M; Verdenik I
Medicina (Kaunas); 2024 Jan; 60(2):. PubMed ID: 38399486
[No Abstract] [Full Text] [Related]
[Next] [New Search]
